MicroRNA targeting of neurotropic flavivirus: Effective control of virus escape and reversion to neurovirulent phenotype

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5647-5659

  Heiss, Brian L ^a,b   Maximova, Olga A ^a   Thach, Dzung C ^a   Speicher, James M ^a   Pletnev, Alexander G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; UNTRANSLATED RNA; VIRUS RNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLAVIVIRUS; GENE DELETION; GENE REPRESSION; GENE TARGETING; IMMUNOGENICITY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERTANT; RNA BINDING; RNA SEQUENCE; SEQUENCE ANALYSIS; VIRUS ATTENUATION; VIRUS ENCEPHALITIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS VIRULENCE;

ANIMALS; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM DISEASES; DENGUE VIRUS; ENCEPHALITIS VIRUSES, TICK-BORNE; FLAVIVIRUS INFECTIONS; GENE TARGETING; HUMANS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PHENOTYPE; VIRULENCE; VIRUS RELEASE; VIRUS REPLICATION;

FLAVIVIRUS; IXODIDA; MUS;

EID: 84861307130     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07125-11     Document Type: Article

References (37)

1. Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX. 1999. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73:5605-5612.
2. Bak M, et al. 2008. MicroRNA expression in the adult mouse central nervous system. RNA 14:432-444.
3. Barh D, Malhotra R, Ravi B, Sindhurani P. 2010. MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr. Oncol. 17(1):70-80.
4. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. 2008. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4:239-248.
5. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
6. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
7. Brown BD, Naldini L. 2009. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 10:578-585.
8. Domingo E, et al. 1996. Basic concepts in RNA virus evolution. FASEB J. 10:859-864.
9. Engel AR, et al. 2010. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome. Virology 405:243-252.
10. Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9:102-114.
11. Gitlin L, Stone JK, Andino R. 2005. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79:1027-1035.
12. Grimson A, et al. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27:91-105.
13. Gritsun TS, Gould EA. 2007. Origin and evolution of 3'UTR of flaviviruses: long direct repeats as a basis for the formation of secondary structures and their significance for virus transmission. Adv. Virus Res. 69:203-248.
14. He L, Hannon GJ. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Genet. 5:522-531.
15. Heiss BL, Maximova OA, Pletnev AG. 2011. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J. Virol. 85:1464-1472.
16. Kelly EJ, Hadac EM, Greiner S, Russell SJ. 2008. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14:1278-1283.
17. Kelly EJ, Russell SJ. 2009. MicroRNAs and regulation of vector tropism. Mol. Ther. 17:409-416.
18. Kelly EJ, Nace R, Barber N, Russell SJ. 2010. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J. Virol. 84: 1550-1562.
19. Kirkegaard K, Baltimore D. 1986. The mechanism of RNA recombination in poliovirus. Cell 47:433-443.
20. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274-1281.
21. Lagos-Quintana M, et al. 2002. Identification of tissue-specific micro-RNAs from mouse. Curr. Biol. 12:735-739.
22. Lin SS, et al. 2009. Molecular evolution of a viral non-coding sequence under the selective pressure of amiRNA-mediated silencing. PLoS Pathog. 5(2):e1000312. doi:10.1371/journal.ppat.1000312.
23. Liu J, et al. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437-1441.
24. Markoff L. 2003. 5'- and 3'-noncoding regions in flavivirus RNA. Adv. Virus Res. 59:177-228.
25. Nagy PD, Simon AE. 1997. New insights into the mechanisms of RNA recombination. Virology 235:1-9.
26. Pathak KB, Nagy PD. 2009. Defective interfering RNAs: foes of viruses and friends of virologists. Viruses 1:895-919.
27. Pijlman GP, et al. 2008. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 4:579-591.
28. Pletnev AG, Bray M, Huggins J, Lai CJ. 1992. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. U. S. A. 89:10532-110536.
29. Pletnev AG, Men R. 1998. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc. Natl. Acad. Sci. U. S. A. 95:1746-1751.
30. Pletnev AG, Swayne DE, Speicher J, Rumyantsev AA, Murphy BR. 2006. Chimeric West Nile virus/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 24:6392-6404.
31. Proutski V, Gritsun TS, Gould EA, Holmes EC. 1999. Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res. 64:107-123.
32. Reed L, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
33. Rumyantsev AA, Chanock RM, Murphy BR, Pletnev AG. 2006. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine 24:133-143.
34. Sempere LF, et al. 2004. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5:R13. http: //genomebiology.com/content/5/3/R13.
35. Skalsky RL, Cullen BR. 2010. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64:123-141.
36. von Eije KJ, ter Brake O, Berkhout B. 2008. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82:2895-2903.
37. Yen LC, et al. 17 October 2011. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine [Epub ahead of print.] doi:10.1016/j.vaccine.2011.09.102.